Aptus Pharma Stock Screener | Share Price & Fundamental Analysis
APPL
Household Appliances
Screen Aptus Pharma share price with our stock screener - analyze fundamentals and track trades in your journal
Market Cap
₹116.57 Cr.
P/B Ratio
5.77
EPS (TTM)
₹6.37
Dividend Yield
-
Debt to Equity
1.79
52W High
-
52W Low
-
Operating Margin
-
Profit Margin
-
EBITDA
-
Net Income
-
Total Assets
₹22.00
Total Equity
₹7.00
Aptus Pharma Share Price History - Stock Screener Chart
Screen APPL historical share price movements with interactive charts. Analyze price trends and patterns.
Aptus Pharma Company Profile - Fundamental Screener
Screen Aptus Pharma company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for APPL shares.
Sector
Consumer Goods
Industry
Household Appliances
Sub-Sector
Household Appliances
Segment
E
ISIN
INE15XJ01010
Aptus Pharma Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen APPL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 |
|---|---|---|---|
| Assets | |||
| Total Assets | 22 | 10 | 6 |
| Current Assets | 20 | 8 | 6 |
| Fixed Assets | 1 | 1 | 1 |
| Liabilities | |||
| Total Liabilities | 22 | 10 | 6 |
| Current Liabilities | 3 | 4 | 2 |
| Non-Current Liabilities | 0 | 0 | 0 |
| Shareholders' Equity | |||
| Total Equity | 7 | 2 | 1 |
| Share Capital | 5 | 0 | 0 |
| Reserves & Surplus | 2 | 2 | 1 |
Screen APPL income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March |
|---|---|---|---|---|
| Revenue | 0 | 25 | 18 | 14 |
| Expenses | 0 | 20 | 16 | 13 |
| EBITDA | 0 | 5 | 2 | 1 |
| Operating Profit % | 0.00% | 20.00% | 9.00% | 4.00% |
| Depreciation | 0 | 0 | 0 | 0 |
| Interest | 0 | 1 | 0 | 0 |
| Profit Before Tax | 0 | 4 | 1 | 0 |
| Tax | 0 | 1 | 0 | 0 |
| Net Profit | 0 | 3 | 1 | 0 |
| EPS | 0.00 | 6.37 | 5.32 | 1.30 |
Aptus Pharma Cash Flow Screener - Liquidity Fundamentals
Screen APPL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March |
|---|---|---|---|
| Operating Activities | -2 | -2 | 0 |
| Investing Activities | -1 | 0 | 0 |
| Financing Activities | 7 | 3 | 1 |
| Net Cash Flow | 4 | 0 | 0 |
Screen APPL shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Jun | 2025-Sept |
|---|---|---|
| Promoter Holding | 72.89% | 72.89% |
| FII Holding | 10.03% | 10.03% |
| DII Holding | 2.80% | 2.80% |
| Govt Holding | 0.00% | 0.00% |
| Public Holding | 11.55% | 11.55% |
| Other Holding | 2.74% | 2.74% |
| Shareholder Count | 9 | 9 |
Aptus Pharma Dividend Screener - Share Yield Analysis
Screen APPL dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Aptus Pharma Index Membership - Market Screener Classification
Screen APPL by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Aptus Pharma Market Events Screener - Corporate Actions
Screen APPL market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2025-11-10 | 2025-11-10 | Quarterly Result Announcement | NA | 12.62% |
Aptus Pharma Competitors Screener - Peer Comparison
Screen APPL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| LG Electronics | 103,839 | 47.68 | 24,631 | 14.26% | 2,203 | 39.51 |
| Voltas | 44,693 | 84.77 | 15,737 | 23.58% | 834 | 44.09 |
| Blue Star | 35,119 | 65.17 | 12,043 | 23.73% | 591 | 36.57 |
| Amber Enterprises | 22,019 | 99.55 | 10,047 | 48.08% | 251 | 30.20 |
| Crompton Greaves | 16,201 | 34.04 | 7,932 | 7.48% | 564 | 36.34 |
| V-Guard Industries | 14,329 | 49.11 | 5,599 | 14.48% | 314 | 38.87 |
| Eureka Forbes | 11,782 | 63.97 | 2,452 | 11.53% | 164 | 43.39 |
| Whirlpool | 11,275 | 32.85 | 8,110 | 15.97% | 363 | 26.36 |
| TTK Prestige | 8,388 | 81.77 | 2,790 | 1.31% | 108 | 34.41 |
| IFB Industries | 6,311 | 50.17 | 5,127 | 14.69% | 119 | 39.27 |
Aptus Pharma Company Announcements - News Screener
Screen APPL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-12-12 | Press Release- Aptus Pharma Expands OTC Presence In Gujarat Strengthens Cosmeceutical Portfolio | View |
| 2025-11-21 | Regulation 30 Disclosure - Entry Into The Urology Therapy Segment | View |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | View |
| 2025-11-12 | Intimation Of New Product- ENZYKING SYRUP | View |
| 2025-11-12 | Intimation Of New Product- SHIROVITA HAIR OIL (AYURVEDIC HAIR OIL) | View |
| 2025-11-11 | Unaudited Financial Results For The Half Year Ended On 30Th September 2025 | View |
| 2025-11-10 | Unaudited Financial Results For The Half Year Ended On 30Th September 2025 | View |
| 2025-11-10 | Board Meeting Outcome for Board Meeting Outcome For Approval Of Unaudited Financial Results For The Half Year Ended On 30Th September 2025 | View |
| 2025-11-01 | Board Meeting Intimation for To Consider And Take On Record Of The Un-Audited Financial Results For The Half Year Ended On 30Th September 2025. | View |
| 2025-10-21 | Clarification On Price Movement | View |
| 2025-10-17 | Clarification sought from Aptus Pharma Ltd | - |
| 2025-10-14 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-01 | Closure of Trading Window | View |
| 2025-09-30 | Listing of Equity Shares of Aptus Pharma Ltd | - |